search
Back to results

Impact of the Different Information Channels in Reducing Anxiety in Participants of Cervical Cancer Screening (DICRA)

Primary Purpose

Uterine Cervical Neoplasms, Early Detection of Cancer, Anxiety

Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Audiovisual information
Written information
Sponsored by
Asociacion Instituto Biodonostia
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Uterine Cervical Neoplasms focused on measuring uterine cervical neoplasms, anxiety, early detection of cancer, uterine cervical cancer screening, cervical cancer screening, cervical cancer, clinical trial, audiovisual intervention

Eligibility Criteria

25 Years - 65 Years (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria: Patients who participate in the Osakidetza cervical cancer screening program and are referred to the colposcopy consultation of the Hospital Universitario Donostia due to an altered screening test. Exclusion Criteria: Patients who have previously been in the colposcopy consultation or have gone to a private center to receive information about their altered result or to undergo colposcopy.

Sites / Locations

  • Donostia University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Audiovisual information

Written information

Arm Description

Group of participants to whom the information is given through an audiovisual medium.

Group of participants to whom the information is given through the writing that is available on the website of the health organization.

Outcomes

Primary Outcome Measures

Change in the level of anxiety measured by the STAI scale according to the information format
Change in the level of anxiety according to the information format Compare the level of anxiety between who have the information in audiovisual format and who have the traditional model in written format. For the analysis we will use the STAI (described in Study description). The analysis of the results will be done by comparing the basic situation of each participant and the response to the same survey after having the information provided. On the other hand, the results of the surveys between both randomized groups will be compared after having access to the information studied.
Change in the level of anxiety measured by the PSS14 scale according to the information format
Change in the level of anxiety according to the information format Compare the level of anxiety between who have the information in audiovisual format and who have the traditional model in written format. For the analysis we will use the PSS14 (described in Study description). The analysis of the results will be done by comparing the basic situation of each participant and the response to the same survey after having the information provided. On the other hand, the results of the surveys between both randomized groups will be compared after having access to the information studied.

Secondary Outcome Measures

Influence of waiting time for colposcopy on anxiety measured by the STAI scale
In this secondary objective, we analyze whether the waiting time from the day the patient knows that she has an altered test until the day of the colposcopy influences the level of anxiety. Generally, the patient has to wait from 2 to 6 weeks from being notified of the altered result until the colposcopy. We are going to group the patients into 3 groups (from 0 to 2 weeks of waiting, from 2 to 4 weeks and from 4 to 6 weeks of waiting) and we will compare the results of the STAI scale to see if this factor is significant in their perception of emotional stress.
Influence of waiting time for colposcopy on anxiety measured by the PSS14 scale
In this secondary objective, we analyze whether the waiting time from the day the patient knows that she has an altered test until the day of the colposcopy influences the level of anxiety. Generally, the patient has to wait from 2 to 6 weeks from being notified of the altered result until the colposcopy. We are going to group the patients into 3 groups (from 0 to 2 weeks of waiting, from 2 to 4 weeks and from 4 to 6 weeks of waiting) and we will compare the results of the PSS14 scale to see if this factor is significant in their perception of emotional stress.
Influence of academic level on anxiety measured by the STAI scale
The level of anxiety obtained through the STAI scale score will be stratified in the 6 educational level categories (none, primary, secondary, high school, university or professional training) to see if there are significant differences between them.
Influence of academic level on anxiety measured by the PSS14 scale
The level of anxiety obtained through the PSS14 scale score will be stratified in the 6 educational level categories (none, primary, secondary, high school, university or professional training) to see if there are significant differences between them.
Change in colposcopy pain perception according to anxiety level measured by the STAI scale
We are going to analyze the pain perceived during the colposcopy, using the VAS scale (Visual Analogue Scale of pain) and we will compare them according to the level of anxiety detected in the STAI scale. We want to determine whether the perception of pain worsens at a higher level of anxiety.
Change in colposcopy pain perception according to anxiety level measured by the PSS14 scale
We are going to analyze the pain perceived during the colposcopy, using the VAS scale (Visual Analogue Scale of pain) and we will compare them according to the level of anxiety detected in the PSS14 scale. We want to determine whether the perception of pain worsens at a higher level of anxiety.

Full Information

First Posted
October 17, 2022
Last Updated
February 1, 2023
Sponsor
Asociacion Instituto Biodonostia
search

1. Study Identification

Unique Protocol Identification Number
NCT05622760
Brief Title
Impact of the Different Information Channels in Reducing Anxiety in Participants of Cervical Cancer Screening
Acronym
DICRA
Official Title
Audiovisual Informative Project for the Participants of the Cervical Cancer Screening in Osakidetza
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Completed
Study Start Date
May 17, 2022 (Actual)
Primary Completion Date
December 28, 2022 (Actual)
Study Completion Date
December 28, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Asociacion Instituto Biodonostia

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
When participating in population-based screening for cervical cancer, women experience great anxiety during the weeks of waiting since they learn that they have an altered screening result until the colposcopy is performed. In this study we want to verify how anxiety decreases when the information is improved and an audiovisual support is added when giving it.
Detailed Description
This study is designed as a double-blind clinical trial. Candidate patients for this study are women referred to a colposcopy consultation after an altered result of the screening test. Those women who have previously been in the colposcopy consultation or have had this test performed in a private center are excluded. The initial recruitment is done by telephone. If they accept, they are given an appointment at the hospital one day where, after being informed again and signing the informed consent, they are randomized and assigned a group. There are 2 groups, in one they receive an envelope with the information in writing that was created in Osakidetza and is available on the website of said organization, and the other group receives a sheet with the links to the videos created for this study in the same envelope. In this way, both groups assume that they are receiving information and we avoid bias. The principal investigator is the one who carries out this phase and distributes the envelopes, but is unaware of their contents. Previously, a collaborator fills in the envelopes according to the randomization code and indicates outside the envelope the order in which they should be delivered. Only she knows the randomization code and she will not reveal it until the end of the study. To analyze the level of anxiety, the participants will fill out 2 scales before receiving the information, and they will return them on the day of the colposcopy before performing it. The scales used are the Spielberger´s State-trait anxiety inventory (STAI) and the Cohen´s PerceivedStress Scale 14 (PSS14). The STAI scale has 40 items, scored from 0 (never) to 3 (very much) points. The final result can range between 0 and 60, higher scores are related to a higher level of anxiety. The PSS14 scale consists of 14 items with a five-point scale response format (0 is never and 4 is very often). The scale scores from 0 to 56; higher scores indicate higher perceived stress. It will also be analyzed whether the waiting time until the colposcopy and the level of academic studies influence the level of anxiety. And the perception of the colposcopy will be analyzed, with the VAS scale, according to their level of anxiety and the way they received the information.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Uterine Cervical Neoplasms, Early Detection of Cancer, Anxiety, Clinical Trial
Keywords
uterine cervical neoplasms, anxiety, early detection of cancer, uterine cervical cancer screening, cervical cancer screening, cervical cancer, clinical trial, audiovisual intervention

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Clinical trial on quality of life where there are 2 groups. After signing the informed consents and completing the anxiety surveys, each participant is randomized and given the corresponding envelope.
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Masking Description
The randomization code is only known to a collaborator who fills the envelopes according to said code. The envelopes are distributed in order of arrival at the study, the researcher in charge of distributing them and recording the information does not know the randomization code. At the end of the study and registering all the data, the collaborator who has the code will deliver it to the principal investigator of the study. In all the envelopes there is some type of information so that the patients are also blind. The experimental group is given a sheet with the links to the videos and the other group is given written information, which is available on the health organization's website. In this way, no group feels that it does not receive information and we control said bias.
Allocation
Randomized
Enrollment
140 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Audiovisual information
Arm Type
Experimental
Arm Description
Group of participants to whom the information is given through an audiovisual medium.
Arm Title
Written information
Arm Type
Placebo Comparator
Arm Description
Group of participants to whom the information is given through the writing that is available on the website of the health organization.
Intervention Type
Other
Intervention Name(s)
Audiovisual information
Intervention Description
The information provided to this group is in audiovisual format. This information is what has been designed with the aim of reducing the level of anxiety of patients who participate in cervical cancer screening.
Intervention Type
Other
Intervention Name(s)
Written information
Intervention Description
The information provided to this group is in written format. This information is what is distributed to patients in the midwife's consultation and is available on the website of the health organization (Osakidetza)
Primary Outcome Measure Information:
Title
Change in the level of anxiety measured by the STAI scale according to the information format
Description
Change in the level of anxiety according to the information format Compare the level of anxiety between who have the information in audiovisual format and who have the traditional model in written format. For the analysis we will use the STAI (described in Study description). The analysis of the results will be done by comparing the basic situation of each participant and the response to the same survey after having the information provided. On the other hand, the results of the surveys between both randomized groups will be compared after having access to the information studied.
Time Frame
Less than 6 weeks between the call notifying the altered result and the colposcopy
Title
Change in the level of anxiety measured by the PSS14 scale according to the information format
Description
Change in the level of anxiety according to the information format Compare the level of anxiety between who have the information in audiovisual format and who have the traditional model in written format. For the analysis we will use the PSS14 (described in Study description). The analysis of the results will be done by comparing the basic situation of each participant and the response to the same survey after having the information provided. On the other hand, the results of the surveys between both randomized groups will be compared after having access to the information studied.
Time Frame
Less than 6 weeks between the call notifying the altered result and the colposcopy
Secondary Outcome Measure Information:
Title
Influence of waiting time for colposcopy on anxiety measured by the STAI scale
Description
In this secondary objective, we analyze whether the waiting time from the day the patient knows that she has an altered test until the day of the colposcopy influences the level of anxiety. Generally, the patient has to wait from 2 to 6 weeks from being notified of the altered result until the colposcopy. We are going to group the patients into 3 groups (from 0 to 2 weeks of waiting, from 2 to 4 weeks and from 4 to 6 weeks of waiting) and we will compare the results of the STAI scale to see if this factor is significant in their perception of emotional stress.
Time Frame
6 weeks maxium
Title
Influence of waiting time for colposcopy on anxiety measured by the PSS14 scale
Description
In this secondary objective, we analyze whether the waiting time from the day the patient knows that she has an altered test until the day of the colposcopy influences the level of anxiety. Generally, the patient has to wait from 2 to 6 weeks from being notified of the altered result until the colposcopy. We are going to group the patients into 3 groups (from 0 to 2 weeks of waiting, from 2 to 4 weeks and from 4 to 6 weeks of waiting) and we will compare the results of the PSS14 scale to see if this factor is significant in their perception of emotional stress.
Time Frame
6 weeks maxium
Title
Influence of academic level on anxiety measured by the STAI scale
Description
The level of anxiety obtained through the STAI scale score will be stratified in the 6 educational level categories (none, primary, secondary, high school, university or professional training) to see if there are significant differences between them.
Time Frame
6 weeks maxium
Title
Influence of academic level on anxiety measured by the PSS14 scale
Description
The level of anxiety obtained through the PSS14 scale score will be stratified in the 6 educational level categories (none, primary, secondary, high school, university or professional training) to see if there are significant differences between them.
Time Frame
6 weeks maxium
Title
Change in colposcopy pain perception according to anxiety level measured by the STAI scale
Description
We are going to analyze the pain perceived during the colposcopy, using the VAS scale (Visual Analogue Scale of pain) and we will compare them according to the level of anxiety detected in the STAI scale. We want to determine whether the perception of pain worsens at a higher level of anxiety.
Time Frame
6 weeks maxium
Title
Change in colposcopy pain perception according to anxiety level measured by the PSS14 scale
Description
We are going to analyze the pain perceived during the colposcopy, using the VAS scale (Visual Analogue Scale of pain) and we will compare them according to the level of anxiety detected in the PSS14 scale. We want to determine whether the perception of pain worsens at a higher level of anxiety.
Time Frame
6 weeks maxium

10. Eligibility

Sex
Female
Gender Based
Yes
Gender Eligibility Description
This clinical trial is aimed at all people with a cervix, regardless of the gender that represents them. Although the vast majority are women, men with a cervix can participate.
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients who participate in the Osakidetza cervical cancer screening program and are referred to the colposcopy consultation of the Hospital Universitario Donostia due to an altered screening test. Exclusion Criteria: Patients who have previously been in the colposcopy consultation or have gone to a private center to receive information about their altered result or to undergo colposcopy.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
David Del Valle, MD
Organizational Affiliation
Osakidetza
Official's Role
Principal Investigator
Facility Information:
Facility Name
Donostia University Hospital
City
San Sebastián
State/Province
Guipuzcoa
ZIP/Postal Code
20014
Country
Spain

12. IPD Sharing Statement

Citations:
PubMed Identifier
6668417
Citation
Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983 Dec;24(4):385-96. No abstract available.
Results Reference
background
PubMed Identifier
16673626
Citation
Remor E. Psychometric properties of a European Spanish version of the Perceived Stress Scale (PSS). Span J Psychol. 2006 May;9(1):86-93. doi: 10.1017/s1138741600006004.
Results Reference
background

Learn more about this trial

Impact of the Different Information Channels in Reducing Anxiety in Participants of Cervical Cancer Screening

We'll reach out to this number within 24 hrs